Palavicini Lab Grants
The Palavicini lab in collaboration with multiple laboratories at UT Health SA and external institutions, frequently submits grant applications to the National Institutes of Health and foundations. Below you can find a list of our most recently funded grants.
Active
2024 William and Ella Owens Medical Research Foundation Award
Palavicini JP (PI)
Koronowski K (co-I)
05/01/2024-04/30/2026
Modeling late-onset Alzheimer’s via gene-environment interactions: Effects of circadian disruption in mice expressing the whole human MAPT gene
The goals of this project are to model LOAD in mice using novel and clinically-relevant combinations of gene-environment interactions and assess the sex-specific effects of circadian asynchrony on AD neuropathologies and cognitive performance.
Total Award Amount (including Indirect Costs): $200,000.00
Pepper OAIC Multi-Center Pilot grant
Palavicini JP (PI)
Murton AJ (co-I)
10/01/2021-09/30/2024
Inhibition of ceramide synthesis: a viable strategy to reverse metabolic determinants of sarcopenic obesity?
The goals of this project are to establish marmosets as a model of sarcopenic obesity and test the hypothesis that ceramide lowering will improve metabolic abnormalities.
Total Award Amount (including Indirect Costs): $100,000.00
Glenn Foundation for Medical Research
and AFAR Grant for Junior Faculty
Palavicini JP (PI)
07/01/2022-06/30/2024
Mechanisms and consequences of ceramide losses in long-lived growth hormone deficient mice
The goal of this study is to test the hypothesis that systemic ceramide reductions are sufficient and necessary for improved healthspan in growth hormone deficient mice.
Total Award Amount (including Indirect Costs): $125,000.00
Alzheimer’s Association AARG-D 846013
Hopp S/Palavicini JP (MPI)
10/01/2021-09/30/2024
PLCG2 AD variants in microglial lipid metabolism and calcium signaling
The goal of this project is to determine the effects of PLCG2 risk and protective variants on brain and microglia lipid metabolism and downstream signaling.
Total Award Amount (including Indirect Costs): $150,000.00
NIH/NIA P30 AG044271 (7978)
Salmon A (PI of RC1)
Palavicini (co-I)
12/01/2023-06/30/2025
RC1-Pre-Clinical Research Core Leader-in-Training
The Pre-clinical Research Core (RC1) of the San Antonio Pepper Older Americans Independence Center provides the knowledge, skills, and technical support to assist investigators in using the common marmoset (Callithrix jacchus) as a pre-clinical model for translational geroscience research.
Completed
Cure Alzheimer’s Fund
Han X/Palavicini JP (MPI)
01/01/2023-12/31/2023
Total Award Amount (including Indirect Costs): $200,000.00
NIH/NIA P30 AG044271 (7973)
PI: Shireman P (REC)/RL5 Scholar: Palavicini JP
12/01/2021-11/31/2023
Total Award Amount (including Indirect Costs): $200,000.00
ADA Grant #1-15-MI-07
Han X (PI)/Palavicini JP (Fellow)
01/01/15 –12/31/17
American Diabetes Association
Role: Postdoctoral Research Fellow.
Mechanistic study on sulfatide deficiency in diabetes and its relationship with dementia.
Total Award Amount (including Indirect Costs): $121,500.00
